Scientific Sessions 2024  /  What’s the Latest in Interventional Cardiology? Clinical Trial and Science Update from TCT/ESC/AHA  /  Panel Discussion
Logo

American Heart Association

  119
  0

Final ID:

Panel Discussion

  • Van Mieghem, Nicolas  ( Erasmsu University MEdical Center , Rotterdam , Netherlands )
  • Chikwe, Joanna  ( Cedars-sinai , Los Aeles , California , United States )
  • Skelding, Kimberly  ( Kimberly Skelding , Ridgewood , Pennsylvania , United States )
  • Mehran, Roxana  ( Icahn School of Med. at Mount Sinai , New York , New York , United States )
  • Al-kazaz, Mohamed  ( Northwestern , Evanston , Illinois , United States )
    • Author Disclosures:
    Nicolas Van Mieghem: DO have relevant financial relationships ; Consultant:abbott:Active (exists now) ; Researcher:PulseCath BV:Active (exists now) ; Researcher:Teleflex:Active (exists now) ; Researcher:Medtronic:Active (exists now) ; Researcher:Boston Scientific:Active (exists now) ; Researcher:Abbbott:Active (exists now) ; Consultant:Amgen:Active (exists now) ; Consultant:JenaValve:Active (exists now) ; Consultant:Anteris:Active (exists now) ; Consultant:PulseCath BV:Active (exists now) ; Consultant:Daiichi Sankyo:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) | Joanna Chikwe: DO NOT have relevant financial relationships | Kimberly Skelding: No Answer | ROXANA MEHRAN: DO have relevant financial relationships ; Consultant:Abbott, Affluent Medical, Alleviant Medical, Amgen, AstraZeneca, BAIM, Beth Israel Deaconess Medical Center, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CERC, Chiesi, Concept Medical, Daiichi Sankyo, Duke, Faraday, Idorsia, Janssen, MedAlliance, Medscape, Mediasphere, Medtelligence, Medtronic, Novartis, OrbusNeich, Pi-Cardia, Protembis, RM Global Bioaccess Fund Management, Sanofi:Active (exists now) ; Advisor:AMA - JAMA Cardiology (Associate Editor), ACC (BOT Member, SC Member CTR Program):Active (exists now) ; Other (please indicate in the box next to the company name):SCAI (Women in Innovations Committee Member), Faculty CRF, Women as One:Active (exists now) ; Individual Stocks/Stock Options:Elixir Medical, Stel, ControlRad (spouse):Active (exists now) ; Speaker:Affluent Medical, Boehringer Ingelheim, Chiesi USA, Cordis, Esperion Science/Innovative Biopharma, Gaffney Events, Educational Trust, Global Clinical Trial Partners, Ltd., IQVIA, Medscape/WebMD Global, NovoNordisk, PeerView Institute for Medical Education, TERUMO Europe N.V., Radcliffe:Active (exists now) | Mohamed Al-Kazaz: DO have relevant financial relationships ; Consultant:Kiniksa pharmaceuticals.:Active (exists now) ; Consultant:Edward Lifesciences:Past (completed) ; Researcher:Kiniksa pharmaceuticals.:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

What’s the Latest in Interventional Cardiology? Clinical Trial and Science Update from TCT/ESC/AHA

Saturday, 11/16/2024 , 03:15PM - 04:30PM

Hall

More abstracts on this topic:
DANGER-SHOCK (primary Results at TCT)

Moller Jacob, Thiele Holger

EARLY-TAVR (primary results at TCT)

Genereux Philippe, Leon Martin

More abstracts from these authors:
Gender Dynamics in Healthcare: Exploring the Impact of Physician-Patient Gender Discordance on Women's Health Outcomes

Harik Lamia, Gaudino Mario, Mehran Roxana, Lau Emily, Chikwe Joanna, Gelijns Annetine, Lawton Jennifer

Panel

Harrington Katherine, Grubb Kendra, Mehran Roxana, Al-kazaz Mohamed

You have to be authorized to contact abstract author. Please, Login
Not Available